Vaishali Pharma Profile
Key Indicators
- Authorised Capital ₹ 22.00 Cr
- Paid Up Capital ₹ 13.05 Cr
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.01 Cr
- Satisfied Charges ₹ 15.12 Cr
- Revenue Growth 39.63%
- Profit Growth 284.58%
- Ebitda 160.36%
- Net Worth 17.56%
- Total Assets -5.22%
About Vaishali Pharma
Vaishali Pharma Limited (VPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 25 April 2008 and has a history of 16 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the National Stock Exchange(NSE) under the ticker symbol VAISHALI.
The Corporate was formerly known as Vaishali Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 22.00 Cr and a paid-up capital of Rs 13.05 Cr.
The company currently has active open charges totaling ₹17.01 Cr. The company has closed loans amounting to ₹15.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vaishali Pharma Limited India are Hemant Pathak as Ceo, Vishwa Mekhia as Company Secretary, and Ratnesh Singh as Cfo. Atul Vasani, Jagruti Vasani, Pratik Jakhelia, and Four other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L52310MH2008PLC181632
- Company No.
181632
- Stock Symbol
NSE : VAISHALI
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2008
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
What products or services does Vaishali Pharma Limited offer?
Vaishali Pharma Limited offers a wide range of products and services, including Multivitamin Tablets & Capsules, Multivitamin Gummy, Calcium Supplements, Calcium Gummies, Vitamin Tablets & Capsules, Vitamin Effervescent Tablet, Nutritional Supplements, L-Arginine Capsules, Calcium Tablet, Calcium Citrate and Vitamin D3 Tablet.
Who are the key members and board of directors at Vaishali Pharma?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Vasani  | Managing Director | 25-Apr-2008 | Current |
| Hemant Pathak | CEO | 26-May-2020 | Current |
| Vishwa Mekhia | Company Secretary | 20-Dec-2021 | Current |
| Ratnesh Singh | CFO | 25-May-2017 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jagruti Vasani | Whole-Time Director | 12-Nov-2009 | Current |
| Pratik Jakhelia | Director | 10-Jul-2021 | Current |
| Dewansh Vasani | Director | 26-Apr-2018 | Current |
| Bhaveshkumar Upadhyay | Additional Director | 03-Oct-2024 | Current |
| Ashvin Ganatra | Director | 31-Dec-2019 | Current |
| Manish Ved | Director | 31-Dec-2019 | Current |
Financial Performance of Vaishali Pharma.
Vaishali Pharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.63% increase. The company also saw a substantial improvement in profitability, with a 284.58% increase in profit. The company's net worth Soared by an impressive increase of 17.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaishali Pharma?
In 2022, Vaishali Pharma had a promoter holding of 26.74% and a public holding of 73.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Magnet Media Solutions LlpBhaveshkumar Upadhyay is a mutual person
- Ei Gennext Consultus Llp
Bhaveshkumar Upadhyay is a mutual person
- Trojan Lifecare Private Limited
Bhaveshkumar Upadhyay is a mutual person
Charges (Loans)
₹17.01 Cr
₹15.12 Cr
Charges Breakdown by Lending Institutions
- Others : 15.26 Cr
- L&T Housing Finance Limited : 1.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2020 | Others | ₹2.60 M | Open |
| 05 Jan 2019 | Others | ₹3.00 Cr | Open |
| 31 Jan 2015 | L&T Housing Finance Limited | ₹1.75 Cr | Open |
| 10 Oct 2013 | Others | ₹12.00 Cr | Open |
| 29 Sep 2020 | Others | ₹8.58 M | Satisfied |
How Many Employees Work at Vaishali Pharma?
Vaishali Pharma has a workforce of 15 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaishali Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaishali Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
